Characterisation of the vasorelaxant properties of the novel endocannabinoid N-arachidonoyl-dopamine (NADA)

British Journal of Pharmacology

Volumn 141, Issue 5, 2004, Pages 803-812

  O'Sullivan, Saoirse E ^a   Kendall, David A ^a   Randall, Michael D ^a  

^a UNIVERSITY OF NOTTINGHAM   (United Kingdom)

Author keywords

Anandamide; Cannabinoid receptor; EDHF; Endothelium; N arachidonoyl dopamine; Rat mesenteric artery; Vanilloid receptor; Vasorelaxation

Indexed keywords

1 (2,4 DICHLOROPHENYL) 5 (4 IODOPHENYL) 4 METHYL N (1 PIPERIDYL) 1H PYRAZOLE 3 CARBOXAMIDE; 8 CHLORO 2,3,4,5 TETRAHYDRO 3 METHYL 5 PHENYL 1H 3 BENZAZEPIN 7 OL HYDROGEN MALEATE; ANANDAMIDE; APAMIN; CANNABINOID; CANNABINOID RECEPTOR AGONIST; CANNABINOID RECEPTOR ANTAGONIST; CAPSAICIN; CAPSAZEPINE; CHARYBDOTOXIN; DOPAMINE 1 RECEPTOR BLOCKING AGENT; DOPAMINE DERIVATIVE; ENDOCANNABINOID; N ARACHIDONOYLDOPAMINE; N(G) NITROARGININE METHYL ESTER; O 1918; POTASSIUM CHANNEL; POTASSIUM CHLORIDE; RIMONABANT; UNCLASSIFIED DRUG; VANILLOID RECEPTOR;

ANIMAL TISSUE; AORTA; ARTERY DILATATION; ARTICLE; ENDOTHELIUM CELL; MALE; NONHUMAN; PRIORITY JOURNAL; RAT; RAT STRAIN; RESISTANCE BLOOD VESSEL; SUPERIOR MESENTERIC ARTERY; VASCULAR ENDOTHELIUM;

ANIMALS; ARACHIDONIC ACIDS; DOPAMINE; DOSE-RESPONSE RELATIONSHIP, DRUG; ENDOCANNABINOIDS; MALE; RATS; RATS, WISTAR; VASODILATION;

EID: 1842611872     PISSN: 00071188     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.bjp.0705643     Document Type: Article

References (32)

1. ADEAGBO, A.S. & TRIGGLE, C.R. (1993). Varying extracellular [K+]: a functional approach to separating EDHF-and EDNO-related mechanisms in perfused rat mesenteric arterial bed. J. Cardiovasc. Pharmacol., 21, 423-429.
2. ANDERSSON, D.A., ADNER, M., HOGESTATT, E.D. & ZYGMUNT, P.M. (2002). Mechanisms underlying tissue selectivity of anandamide and other vanilloid receptor agonists. Mol. Pharmacol., 62, 705-713.
3. BISOGNO, T., MELCK, D., BOBROV, M.Y.U., GRETSKAYA, N.M., BEZUGLOV, V.V., DE PETROCELLIS, L. & DI MARZO, V. (2000). N-acyl-dopamines: novel synthetic CB(1) cannabinoid-receptor ligands and inhibitors of anandamide inactivation with cannabimimetic activity in vitro and in vivo. Biochem. J., 351, 817-824.
4. CHAYTOR, A.T., MARTIN, P.E., EVANS, W.H., RANDALL, M.D. & GRIFFITH, T.M. (1999). The endothelial component of cannabinoid-induced relaxation in rabbit mesenteric artery depends on gap junctional communication. J. Physiol., 520, 539-550.
5. CHU, C.J., HUANG, S.M., DE PETROCELLIS, L., BISOGNO, T., EWING, S.A., MILLER, J.D., ZIPKIN, R.E., DADDARIO, N., APPENDINO, G., DI MARZO, V. & WALKER, J.M. (2003). N-oleoyldopamine, a novel endogenous capsaicin-like lipid that produces hyperalgesia. J. Biol. Chem., 278, 13633-13639.
6. DE PETROCELLIS, L., BISOGNO, T., MACCARRONE, M., DAVIS, J.B., FINAZZI-AGRO, A. & DI MARZO, V. (2001). The activity of anandamide at vanilloid VR1 receptors requires facilitated transport across the cell membrane and is limited by intracellular metabolism. J. Biol. Chem., 276, 12856-12863.
7. DEUTSCH, D.G., GOLIGORSKY, M.S., SCHMID, P.G., KREBSBACH, R.J., SCHMID, R.J., DAS, S.K., DEY, S.K., ARREAZA, G., THORUP, C., STEFANO, G. & MOORE, L.C. (1997). Production and physiological actions of anandamide in the vasculature of the rat kidney. J. Clin. Invest., 100, 1538-1546.
8. 1 receptor antagonist, AM 251, on the regional haemodynamic effects of WIN-55212-2 or HU 210 in conscious rats. Br. J. Pharmacol., 136, 581-587.
9. GOLDBERG, L.I. (1985). Dopamine: receptors and clinical applications. Clin. Physiol. Biochem., 3, 120-126.
10. HARRIS, D., MCCULLOCH, A.I., KENDALL, D.A. & RANDALL, M.D. (2002). Characterisation of vasorelaxant responses to anandamide in the rat mesenteric arterial bed. J. Physiol., 539, 893-902.
11. HARRISON, S., DE PETROCELLIS, L., TREVISANI, M., BENVENUTI, F., BIFULCO, M., GEPPETTI, P. & DI MARZO, V. (2003). Capsaicin-like effects of N-arachidonoyl-dopamine in the isolated guinea pig bronchi and urinary bladder. Eur. J. Pharmacol., 475, 107-114.
12. 2+ influx. Br. J. Pharmacol., 139, 585-597.
13. HUANG, S.M., BISOGNO, T., TREVISANI, M., AL-HAYANI, A., DE PETROCELLIS, L., FEZZA, F., TOGNETTO, M., PETROS, T.J., KREY, J.F., CHU, C.J., MILLER, J.D., DAVIES, S.N., GEPPETTI, P., WALKER, J.M. & DI MARZO, V. (2002). An endogenous capsaicin-like substance with high potency at recombinant and native vanilloid VR1 receptors. Proc. Natl. Acad. Sci. U.S.A., 99, 8400-8405.
14. JÁRAI, Z., WAGNER, J.A., VARGA, K., LAKE, K.D., COMPTON, D.R., MARTIN, B.R., ZIMMER, A.M., BONNER, T.I., BUCKLEY, N.E., MEZEY, E., RAZDAN, R.K., ZIMMER, A. & KUNOS, G. (1999). Cannabinoid-induced mesenteric vasodilation through an endothelial site distinct from CB1 or CB2 receptors. Proc. Natl. Acad. Sci. U.S.A., 96, 14136-14141.
15. MARTIN, S.W. & BROADLEY, K.J. (1995). Atypical antagonism of D1-receptor-mediated vasodilator response in the perfused kidney by SCH23390. Pharmacol. Res., 31, 289-297.
16. MATSUDA, L.A., LOLAIT, S.J., BROWNSTEIN, M.J., YOUNG, A.C. & BONNER, T.L. (1990). Structure of a cannabinoid receptor and functional expression of the cloned cDNA. Nature, 346, 561-564.
17. MCCULLOCH, A.I., BOTTRILL, F.E., RANDALL, M.D. & HILEY, C.R. (1997). Characterisation and modulation of EDHF-mediated relaxations in the rat isolated superior mesenteric arterial bed. Br. J. Pharmacol., 120, 1431-1438.
18. MULVANY, M.J. & HALPERN, W. (1977). Contractile properties of small arterial resistance vessels in spontaneously hypertensive and normotensive rats. Circ. Res., 41, 19-26.
19. OFFERTÁLER, L., MO, F.M., BATKAI, S., LIU, J., BEGG, M., RAZDAN, R.K., MARTIN, B.R., BUKOSKI, R.D. & KUNOS, G. (2003). Selective ligands and cellular effectors of a G protein-coupled endothelial cannabinoid receptor. Mol. Pharmacol., 63, 699-705.
20. RALEVIC, V., KENDALL, D.A., RANDALL, M.D., ZYGMUNT, P.M., MOVAHED, P. & HÖGESTÄTT, E.D. (2000). Vanilloid receptors on capsaicin-sensitive sensory nerves mediate relaxation to methanandamide in the rat isolated mesenteric arterial bed and small mesenteric arteries. Br. J. Pharmacol., 130, 1483-1488.
21. RANDALL, M.D., ALEXANDER, S.P.H., BENNETT, T., BOYD, E.A., FRY, J.R., GARDINER, S.M., KEMP, P.A., MCCULLOCH, A.I. & KENDALL, D.A. (1996). An endogenous cannabinoid as an endothelium-derived vasorelaxant. Biochem. Biophys. Res. Commun., 229, 114-120.
22. G-nitro-L-arginine methyl ester of basal and agonist-stimulated EDRF activity. Br. J. Pharmacol., 104, 743-749.
23. RANDALL, M.D., HARRIS, D., KENDALL, D. & RALEVIC, V. (2002). Cardiovascular effects of cannabinoids. Pharm. Ther., 95, 191-202.
24. RANDALL, M.D. & KENDALL, D.A. (1998). Anandamide and endothelium-derived hyperpolarising factor act via a common vasorelaxant mechanism in rat mesentery. Eur. J. Pharmacol., 346, 51-53.
25. RINALDI-CARMONA, M., BARTH, F., HEAULME, M., SHIRE, D., CALANDRA, B., CONGY, C., MARTINEZ, S., MARUANI, J., NELIAT, G., CAPUT, D., FERRARA, P., SOUBRIÉ, P., BRELIÉRE, J.C. & LE FUR, G. (1994). SR141716A, a potent and selective antagonist of the brain cannabinoid receptor. FEBS Lett., 350, 240-244.
26. TEP-AREENAN, P., KENDALL, D.A. & RANDALL, M.D. (2003). Mechanisms of vasorelaxation to testosterone in the rat aorta. Eur. J. Pharmacol., 465, 125-132.
27. VANHEEL, B. & VAN DE VOORDE, J. (2001). Regional differences in anandamide-and methanandamide-induced membrane potential changes in rat mesenteric arteries. J. Pharmacol. Exp. Ther., 296, 322-328.
28. WAGNER, J.A., VARGA, K., ELLIS, E.F., RZIGALINSKI, B.A., MARTIN, B.R. & KUNOS, G. (1997). Activation of peripheral CB1 cannabinoid receptors in haemorrhagic shock. Nature, 390, 518-521.
29. WHITE, R. & HILEY, C.R. (1997). A comparison of EDHF-mediated and anandamide-induced relaxations in the rat isolated mesenteric artery. Br. J. Pharmacol., 122, 1573-1584.
30. WHITE, R., HO, W.S., BOTTRILL, F.E., FORD, W.R. & HILEY, C.R. (2001). Mechanisms of anandamide-induced vasorelaxation in rat isolated coronary arteries. Br. J. Pharmacol., 134, 921-929.
31. ZYGMUNT, P.M., HOGESTATT, E.D., WALDECK, K., EDWARDS, G., KIRKUP, A.J. & WESTON, A.H. (1997). Studies on the effects of anandamide in rat hepatic artery. Br. J. Pharmacol., 122, 1679-1686.
32. ZYGMUNT, P.M., PETERSSON, J., ANDERSSON, D.A., CHUANG, H.H., SORGARD, M., DI MARZO, V., JULIUS, D. & HOGESTATT, E.D. (1999). Vanilloid receptors on sensory nerves mediate the vasodilator action of anandamide. Nature, 400, 452-457.